Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II, Prospective, Single-Arm, Single-Center Clinical Trial of CD38 Monoclonal Antibody Combined With a Pediatric-Inspired Chemotherapy Regimen for Induction Therapy in Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

NCT07585734 is registered in ClinicalTrials.gov with Institute of Hematology & Blood Diseases Hospital, China as lead sponsor.

NCT NCT07585734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07585734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II, Prospective, Single-Arm, Single-Center Clinical Trial of CD38 Monoclonal Antibody Combined With a Pediatric-Inspired Chemotherapy Regimen for Induction Therapy in Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
Lead sponsor
Institute of Hematology & Blood Diseases Hospital, China
Phase
Phase 1/2
Overall status
Withdrawn
Start date
April 30, 2025
Completion date
April 30, 2027
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

t-all